首页|Cancer Hospital Reports Findings in Lung Cancer (Advancing predictive markers in lung adenocarcinoma: A machine learning-based immunotherapy prognostic predicti on signature)
Cancer Hospital Reports Findings in Lung Cancer (Advancing predictive markers in lung adenocarcinoma: A machine learning-based immunotherapy prognostic predicti on signature)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Lung Cancer is the subject of a report. According to newsoriginating from Beijing, People’ s Republic of China, by NewsRx correspondents, research stated, “Theprognosis o f lung adenocarcinoma (LUAD) is generally poor. Immunotherapy has emerged as a p romisingtherapeutic modality, demonstrating remarkable potential for substantia lly prolonging the overall survivalof individuals afflicted with LUAD.”
BeijingPeople’s Republic of ChinaAsi aAdenocarcinomaBiomarkersCancerCyborgsDiagnostics and ScreeningDrugs and TherapiesEmerging TechnologiesHealth and MedicineImmunotherapyLung CancerLung Diseases and ConditionsMachine Learning
NETL
NSTL
